Rotavirus Spike Protein VP4 Mediates Viroplasm Assembly by Association to Actin Filaments.
VP4
actin
reverse genetic analysis
reverse-genetics
rotavirus
spike
spike protein
viroplasm
Journal
Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724
Informations de publication
Date de publication:
14 09 2022
14 09 2022
Historique:
pubmed:
9
8
2022
medline:
17
9
2022
entrez:
8
8
2022
Statut:
ppublish
Résumé
Rotavirus (RV) viroplasms are cytosolic inclusions where both virus genome replication and primary steps of virus progeny assembly take place. A stabilized microtubule cytoskeleton and lipid droplets are required for the viroplasm formation, which involves several virus proteins. The viral spike protein VP4 has not previously been shown to have a direct role in viroplasm formation. However, it is involved with virus-cell attachment, endocytic internalization, and virion morphogenesis. Moreover, VP4 interacts with actin cytoskeleton components, mainly in processes involving virus entrance and egress, and thereby may have an indirect role in viroplasm formation. In this study, we used reverse genetics to construct a recombinant RV, rRV/VP4-BAP, that contains a biotin acceptor peptide (BAP) in the K145-G150 loop of the VP4 lectin domain, permitting live monitoring. The recombinant virus was replication competent but showed a reduced fitness. We demonstrate that rRV/VP4-BAP infection, as opposed to rRV/wt infection, did not lead to a reorganized actin cytoskeleton as viroplasms formed were insensitive to drugs that depolymerize actin and inhibit myosin. Moreover, wild-type (wt) VP4, but not VP4-BAP, appeared to associate with actin filaments. Similarly, VP4 in coexpression with NSP5 and NSP2 induced a significant increase in the number of viroplasm-like structures. Interestingly, a small peptide mimicking loop K145-G150 rescued the phenotype of rRV/VP4-BAP by increasing its ability to form viroplasms and hence improve virus progeny formation. Collectively, these results provide a direct link between VP4 and the actin cytoskeleton to catalyze viroplasm assembly.
Identifiants
pubmed: 35938869
doi: 10.1128/jvi.01074-22
pmc: PMC9472636
doi:
Substances chimiques
Capsid Proteins
0
Lectins
0
VP4 protein, Rotavirus
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0107422Références
Microbiol Immunol. 2003;47(8):613-7
pubmed: 14524622
Virology. 2022 Apr;569:29-36
pubmed: 35240536
J Virol. 2019 Dec 12;94(1):
pubmed: 31619556
J Virol. 2006 Nov;80(22):11293-304
pubmed: 16971442
J Virol. 2013 Feb;87(3):1658-63
pubmed: 23175367
J Virol. 2009 Nov;83(21):11372-7
pubmed: 19692464
J Virol. 1979 Sep;31(3):810-5
pubmed: 229253
Curr Protoc Microbiol. 2009 Nov;Chapter 15:Unit 15C.3
pubmed: 19885940
J Gen Virol. 2004 Mar;85(Pt 3):625-634
pubmed: 14993647
J Virol. 2003 Jun;77(12):7041-7
pubmed: 12768023
PLoS One. 2012;7(10):e47947
pubmed: 23110139
Proc Natl Acad Sci U S A. 1986 Nov;83(21):8122-6
pubmed: 3095828
Viruses. 2021 Jul 12;13(7):
pubmed: 34372555
J Virol. 2017 Aug 24;91(18):
pubmed: 28701394
Curr Opin Virol. 2021 Jun;48:42-48
pubmed: 33887683
Cell. 2002 Jan 11;108(1):71-81
pubmed: 11792322
EMBO J. 2011 Jan 19;30(2):408-16
pubmed: 21157433
J Gen Virol. 2005 May;86(Pt 5):1481-1487
pubmed: 15831961
J Gen Virol. 2012 Jul;93(Pt 7):1474-1482
pubmed: 22442113
J Virol. 2010 Jul;84(13):6782-98
pubmed: 20335253
Viruses. 2020 Feb 13;12(2):
pubmed: 32069901
Elife. 2018 Sep 11;7:
pubmed: 30201094
Virology. 1990 Sep;178(1):143-51
pubmed: 2167546
J Virol. 2020 Mar 17;94(7):
pubmed: 31915278
Nature. 2004 Aug 26;430(7003):1053-8
pubmed: 15329727
Virology. 2000 Nov 25;277(2):420-8
pubmed: 11080489
J Virol. 2000 Apr;74(7):3313-20
pubmed: 10708448
EMBO J. 2001 Apr 2;20(7):1498-507
pubmed: 11285214
Virology. 1986 Dec;155(2):434-51
pubmed: 2431540
EMBO J. 2006 Apr 5;25(7):1559-68
pubmed: 16511559
Can Vet J. 2017 Dec;58(12):1267-1274
pubmed: 29203935
J Virol. 2002 Apr;76(7):3461-70
pubmed: 11884570
J Virol. 2011 Mar;85(6):2492-503
pubmed: 21191022
J Virol. 2000 Jan;74(2):593-9
pubmed: 10623720
Virus Res. 2021 Apr 2;295:198296
pubmed: 33440223
N Engl J Med. 2006 Jan 5;354(1):11-22
pubmed: 16394298
J Virol. 2018 Feb 26;92(6):
pubmed: 29263265
J Clin Microbiol. 1987 May;25(5):952-4
pubmed: 3034969
BMC Biotechnol. 2008 Apr 18;8:41
pubmed: 18423015
Cell Rep. 2020 Sep 29;32(13):108205
pubmed: 32997981
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
EMBO J. 2002 Mar 1;21(5):885-97
pubmed: 11867517
Virus Res. 2019 Apr 2;263:27-33
pubmed: 30639190
Curr Protoc Protein Sci. 2013 Nov 05;74:19.23.1-19.23.14
pubmed: 24510646
J Virol. 2018 Nov 27;92(24):
pubmed: 30258012
J Virol. 2018 Jan 17;92(3):
pubmed: 29142132
J Gen Virol. 2010 Jul;91(Pt 7):1782-93
pubmed: 20200190
J Virol. 2018 Dec 10;93(1):
pubmed: 30333172
Vet Q. 2015;35(3):142-58
pubmed: 25917772
J Virol. 2009 Feb;83(4):1754-66
pubmed: 19036817
Vaccine. 2006 May 29;24(22):4821-9
pubmed: 16621194
Mol Cell. 2002 Jun;9(6):1273-83
pubmed: 12086624
Methods Mol Biol. 2015;1266:171-84
pubmed: 25560075
J Virol. 1998 Jun;72(6):5323-7
pubmed: 9573313
Virology. 1988 Nov;167(1):166-75
pubmed: 3263730
J Virol. 2007 May;81(9):4892-4
pubmed: 17301135
PLoS Pathog. 2014 Sep 11;10(9):e1004355
pubmed: 25211455
PLoS One. 2017 Jun 16;12(6):e0179607
pubmed: 28622358
J Virol. 1996 Sep;70(9):5832-9
pubmed: 8709201
J Virol. 2006 Apr;80(8):3947-56
pubmed: 16571811
Proc Natl Acad Sci U S A. 2017 May 2;114(18):E3642-E3651
pubmed: 28416666
J Virol. 2017 Oct 13;91(21):
pubmed: 28794037
Biochem Biophys Res Commun. 2018 Nov 25;506(2):394-402
pubmed: 29550471
EMBO Rep. 2002 Dec;3(12):1175-80
pubmed: 12446562
J Muscle Res Cell Motil. 2004;25(4-5):337-41
pubmed: 15548862
J Virol. 2002 Aug;76(15):7822-31
pubmed: 12097594
Protein Sci. 1999 Apr;8(4):921-9
pubmed: 10211839
EMBO J. 1998 Oct 1;17(19):5811-21
pubmed: 9755181
J Virol. 2003 Sep;77(18):9969-78
pubmed: 12941907
Nat Rev Microbiol. 2012 Jan 23;10(3):165-77
pubmed: 22266782
Proc Natl Acad Sci U S A. 2017 Feb 28;114(9):2349-2354
pubmed: 28137864
Mol Biol Cell. 2011 Nov;22(21):4047-58
pubmed: 21900491
Viruses. 2017 Mar 18;9(3):
pubmed: 28335454
PLoS One. 2012;7(10):e47612
pubmed: 23082182
J Virol. 2002 Apr;76(8):4096-102
pubmed: 11907249
J Virol. 1997 Oct;71(10):7353-60
pubmed: 9311813
J Virol. 2003 Jul;77(13):7254-60
pubmed: 12805424
J Mol Biol. 2019 Jan 18;431(2):123-141
pubmed: 30367842
JAMA Pediatr. 2018 Oct 1;172(10):958-965
pubmed: 30105384
J Virol. 2007 Mar;81(5):2128-37
pubmed: 17182692
J Gen Virol. 2006 May;87(Pt 5):1275-1283
pubmed: 16603530
Proc Natl Acad Sci U S A. 2011 Jan 25;108(4):1531-6
pubmed: 21205896
Mol Ther. 2012 Sep;20(9):1810-20
pubmed: 22713696
Virology. 1991 Apr;181(2):553-63
pubmed: 1849677
Nature. 2021 Feb;590(7847):666-670
pubmed: 33442061
J Virol. 2006 Sep;80(18):9031-8
pubmed: 16940515
EMBO J. 2021 Nov 2;40(21):e107711
pubmed: 34524703
Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):1867-72
pubmed: 18238898
PLoS One. 2014 May 06;9(5):e96700
pubmed: 24802141
Proc Natl Acad Sci U S A. 2005 Mar 15;102(11):4114-9
pubmed: 15741273
Curr Opin Virol. 2012 Aug;2(4):389-98
pubmed: 22658208
Curr Top Microbiol Immunol. 2006;309:169-87
pubmed: 16909900
J Virol. 2015 Jan 15;89(2):890-3
pubmed: 25378490
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1997 Feb;19(1):48-53
pubmed: 10453552
J Virol. 2010 Feb;84(4):1764-70
pubmed: 20007281
J Gen Virol. 1999 Feb;80 ( Pt 2):333-339
pubmed: 10073692
J Biol Chem. 2010 Jun 11;285(24):18123-8
pubmed: 20351108